Post by Symeres

Polymersomes are one of the most promising platforms in drug delivery. So why are so few making it to the clinic? As complexity increases across polymer design, characterization, scale-up, and regulatory expectations, the real challenge becomes integration: making sure chemistry, manufacturing, and controls are aligned from the start. For many development teams, progress comes from having the right support in place to connect these disciplines early, so decisions are grounded, scalable, and easier to advance with confidence. This is where Symeres works alongside customers, combining advanced polymer chemistry, deep analytical expertise, and practical scale-up thinking to help reduce translation risk. Where do you see the biggest barrier today? Design, analytics, or scalable manufacturing? 💭 👉 Want to know more about Bridging the Polymersome Development Gap? Read the article here: https://brnw.ch/21x3W8d